180 related articles for article (PubMed ID: 20100838)
1. Promyelocytic leukemia protein controls cell migration in response to hydrogen peroxide and insulin-like growth factor-1.
Reineke EL; Liu Y; Kao HY
J Biol Chem; 2010 Mar; 285(13):9485-9492. PubMed ID: 20100838
[TBL] [Abstract][Full Text] [Related]
2. Degradation of the tumor suppressor PML by Pin1 contributes to the cancer phenotype of breast cancer MDA-MB-231 cells.
Reineke EL; Lam M; Liu Q; Liu Y; Stanya KJ; Chang KS; Means AR; Kao HY
Mol Cell Biol; 2008 Feb; 28(3):997-1006. PubMed ID: 18039859
[TBL] [Abstract][Full Text] [Related]
3. Mitogen-activated protein kinase extracellular signal-regulated kinase 2 phosphorylates and promotes Pin1 protein-dependent promyelocytic leukemia protein turnover.
Lim JH; Liu Y; Reineke E; Kao HY
J Biol Chem; 2011 Dec; 286(52):44403-11. PubMed ID: 22033920
[TBL] [Abstract][Full Text] [Related]
4. Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer.
Wei S; Kozono S; Kats L; Nechama M; Li W; Guarnerio J; Luo M; You MH; Yao Y; Kondo A; Hu H; Bozkurt G; Moerke NJ; Cao S; Reschke M; Chen CH; Rego EM; Lo-Coco F; Cantley LC; Lee TH; Wu H; Zhang Y; Pandolfi PP; Zhou XZ; Lu KP
Nat Med; 2015 May; 21(5):457-66. PubMed ID: 25849135
[TBL] [Abstract][Full Text] [Related]
5. Promyelocytic leukemia protein (PML) regulates endothelial cell network formation and migration in response to tumor necrosis factor α (TNFα) and interferon α (IFNα).
Cheng X; Liu Y; Chu H; Kao HY
J Biol Chem; 2012 Jul; 287(28):23356-67. PubMed ID: 22589541
[TBL] [Abstract][Full Text] [Related]
6. SCP phosphatases suppress renal cell carcinoma by stabilizing PML and inhibiting mTOR/HIF signaling.
Lin YC; Lu LT; Chen HY; Duan X; Lin X; Feng XH; Tang MJ; Chen RH
Cancer Res; 2014 Dec; 74(23):6935-46. PubMed ID: 25293974
[TBL] [Abstract][Full Text] [Related]
7. TGF-β1-PML SUMOylation-peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (Pin1) form a positive feedback loop to regulate cardiac fibrosis.
Wu D; Huang D; Li LL; Ni P; Li XX; Wang B; Han YN; Shao XQ; Zhao D; Chu WF; Li BY
J Cell Physiol; 2019 May; 234(5):6263-6273. PubMed ID: 30246389
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic effect of arsenic trioxide on acute promyelocytic leukemia cells through suppression of NFkβ-dependent induction of hTERT due to down-regulation of Pin1 transcription.
Ghaffari SH; Momeny M; Bashash D; Mirzaei R; Ghavamzadeh A; Alimoghaddam K
Hematology; 2012 Jul; 17(4):198-206. PubMed ID: 22944098
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the peptidyl-prolyl-isomerase Pin1 enhances the responses of acute myeloid leukemia cells to retinoic acid via stabilization of RARalpha and PML-RARalpha.
Gianni' M; Boldetti A; Guarnaccia V; Rambaldi A; Parrella E; Raska I; Rochette-Egly C; Del Sal G; Rustighi A; Terao M; Garattini E
Cancer Res; 2009 Feb; 69(3):1016-26. PubMed ID: 19155306
[TBL] [Abstract][Full Text] [Related]
10. (-)-Epigallocatechin-3-gallate induces apoptosis and differentiation in leukaemia by targeting reactive oxygen species and PIN1.
Della Via FI; Shiraishi RN; Santos I; Ferro KP; Salazar-Terreros MJ; Franchi Junior GC; Rego EM; Saad STO; Torello CO
Sci Rep; 2021 Apr; 11(1):9103. PubMed ID: 33907248
[TBL] [Abstract][Full Text] [Related]
11. A suppressive role of the prolyl isomerase Pin1 in cellular apoptosis mediated by the death-associated protein Daxx.
Ryo A; Hirai A; Nishi M; Liou YC; Perrem K; Lin SC; Hirano H; Lee SW; Aoki I
J Biol Chem; 2007 Dec; 282(50):36671-81. PubMed ID: 17938171
[TBL] [Abstract][Full Text] [Related]
12. Peroxide-mediated oxidation and inhibition of the peptidyl-prolyl isomerase Pin1.
Innes BT; Sowole MA; Gyenis L; Dubinsky M; Konermann L; Litchfield DW; Brandl CJ; Shilton BH
Biochim Biophys Acta; 2015 May; 1852(5):905-12. PubMed ID: 25595659
[TBL] [Abstract][Full Text] [Related]
13. The peptidyl-isomerase Pin1 regulates p27kip1 expression through inhibition of Forkhead box O tumor suppressors.
Brenkman AB; de Keizer PL; van den Broek NJ; van der Groep P; van Diest PJ; van der Horst A; Smits AM; Burgering BM
Cancer Res; 2008 Sep; 68(18):7597-605. PubMed ID: 18794148
[TBL] [Abstract][Full Text] [Related]
14. Deacetylation of the tumor suppressor protein PML regulates hydrogen peroxide-induced cell death.
Guan D; Lim JH; Peng L; Liu Y; Lam M; Seto E; Kao HY
Cell Death Dis; 2014 Jul; 5(7):e1340. PubMed ID: 25032863
[TBL] [Abstract][Full Text] [Related]
15. Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML.
Ahn MJ; Nason-Burchenal K; Moasser MM; Dmitrovsky E
Oncogene; 1995 Jun; 10(12):2307-14. PubMed ID: 7784078
[TBL] [Abstract][Full Text] [Related]
16. PML-RAR alpha induces the downmodulation of HHEX: a key event responsible for the induction of an angiogenetic response.
Saulle E; Petronelli A; Pelosi E; Coppotelli E; Pasquini L; Ilari R; Lo-Coco F; Testa U
J Hematol Oncol; 2016 Apr; 9():33. PubMed ID: 27052408
[TBL] [Abstract][Full Text] [Related]
17. PML(NLS(-)) inhibits cell apoptosis and promotes proliferation in HL-60 cells.
Gao YM; Zhong L; Zhang X; Hu XX; Liu BZ
Int J Med Sci; 2013; 10(5):498-507. PubMed ID: 23532460
[TBL] [Abstract][Full Text] [Related]
18. Halofuginone has anti-proliferative effects in acute promyelocytic leukemia by modulating the transforming growth factor beta signaling pathway.
de Figueiredo-Pontes LL; Assis PA; Santana-Lemos BA; Jácomo RH; Lima AS; Garcia AB; Thomé CH; Araújo AG; Panepucci RA; Zago MA; Nagler A; Falcão RP; Rego EM
PLoS One; 2011; 6(10):e26713. PubMed ID: 22053203
[TBL] [Abstract][Full Text] [Related]
19. Blockade of the ubiquitin protease UBP43 destabilizes transcription factor PML/RARα and inhibits the growth of acute promyelocytic leukemia.
Guo Y; Dolinko AV; Chinyengetere F; Stanton B; Bomberger JM; Demidenko E; Zhou DC; Gallagher R; Ma T; Galimberti F; Liu X; Sekula D; Freemantle S; Dmitrovsky E
Cancer Res; 2010 Dec; 70(23):9875-85. PubMed ID: 20935222
[TBL] [Abstract][Full Text] [Related]
20. Epstein - Barr virus Latent Membrane Protein 1 suppresses reporter activity through modulation of promyelocytic leukemia protein-nuclear bodies.
Sides MD; Block GJ; Chadwick RW; Shan B; Flemington EK; Lasky JA
Virol J; 2011 Oct; 8():461. PubMed ID: 21975125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
